Other significant risks include acute pancreatitis, hypoglycemia when combined with insulin or sulfonylureas, acute kidney injury (particularly in the setting of severe gastrointestinal symptoms), diabetic retinopathy complications, and gallbladder disease
Maintenance should prevent relapse between injections, not follow a rigid interval if symptoms return
[PMID: 39779063] PubMed record related to this compound for laboratory literature review
Film-coating: black ferrosoferric oxide and ferric oxide red (12.5 mg/500 mg, 12.5 mg/1,000 mg) or ferric oxide yellow (5 mg/500 mg, 5 mg/1,000 mg), hypromellose, polyethylene glycol 400, talc and titanium dioxide
Both promote wound healing and tissue repair
With consistent use, you can expect steady progress toward your weight loss goals